+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Surgical treatment and outcome in children with tuberous sclerosis complex and intractable epilepsy in relation to alpha- methyl-L-tryptophan PET



Surgical treatment and outcome in children with tuberous sclerosis complex and intractable epilepsy in relation to alpha- methyl-L-tryptophan PET



Neurology 60(5 Suppl. 1): A448-A449




Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 035801508

Download citation: RISBibTeXText


Related references

Epilepsy surgery outcome in children with tuberous sclerosis complex evaluated with alpha-[11C]methyl-L-tryptophan positron emission tomography (PET). Journal of Child Neurology 20(5): 429-438, 2005

Epilepsy Surgery Outcome in Children With Tuberous Sclerosis Complex Evaluated With -[11C]Methyl-L-Tryptophan Positron Emission Tomography (Pet). Journal of Child Neurology 20(5): 429-438, 2005

Refractory epilepsy in preschool children with tuberous sclerosis complex: Early surgical treatment and outcome. Seizure 60: 71-79, 2018

Surgical treatment for intractable epilepsy caused by tuberous sclerosis complex with multiple tubers: case report. No Shinkei Geka. Neurological Surgery 36(2): 155-158, 2008

Imaging epileptogenic tubers in children with tuberous sclerosis complex using alpha-[11C]methyl-L-tryptophan positron emission tomography. Annals of Neurology 44(6): 858-866, 1998

Evidence alpha methyl-L-tryptophan PET traces tryptophan metabolism via the kynurenine pathway in tuberous sclerosis complex. Society for Neuroscience Abstracts 24(1-2): 1757, 1998

Alpha methyl-L-tryptophan pet patterns in tuberous sclerosis patients with autism and epilepsy. Society for Neuroscience Abstracts 25(1-2): 489, 1999

Positron emission tomography with α-[11C]methyl-L-tryptophan in tuberous sclerosis complex-related epilepsy. Epilepsia 54(12): 2143-2150, 2013

Predictors of seizure outcomes in children with tuberous sclerosis complex and intractable epilepsy undergoing resective epilepsy surgery: an individual participant data meta-analysis. Plos one 8(2): E53565, 2013

Treatment of intractable epilepsy in tuberous sclerosis complex with everolimus is not yet evidence-based. Annals of Neurology 75(1): 163-164, 2014

Epilepsy surgery outcome in children with focal epilepsy due to tuberous sclerosis complex. Neuropediatrics 33(5): 255-261, 2003

O45 1612 Rate: randomised clinical trial of rapamycin in children with tuberous sclerosis complex and intractable epilepsy. European Journal of Paediatric Neurology 17: S14-S15, 2013

A partial least squares analysis of seizure outcomes following resective surgery for tuberous sclerosis complex in children with intractable epilepsy. Child's Nervous System 31(2): 181-184, 2015

Alpha-methyl-L-tryptophan PET detects epileptogenic cortex in children with intractable epilepsy. Neurology 60(6): 960-968, 2003

Clinical and histopathologic correlates of 11C-alpha-methyl-L-tryptophan (AMT) PET abnormalities in children with intractable epilepsy. Epilepsia 52(9): 1692-1698, 2011